Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort

Background In familial amyotrophic lateral sclerosis (ALS) cases, the presence of an abnormal C9ORF72 repeat expansion (C9RE) is the most frequent genetic cause identified. Various clinical phenotypes have been described in relation to the presence of C9RE, including psychiatric disorders or Huntington-like symptoms. In a subset of sporadic ALS, C9RE has also been described. In the present study, all index cases with ALS and C9RE identified in our center and their clinical profile, as well as neurological and psychiatric characteristics of identified family members, were described. Clinical characteristics of ALS patients were compared to 999 patients with sporadic ALS (SALS) from our database. Results From the 70 index cases with ALS identified, a total of 200 individuals were studied, 118 with ALS, 32 with fronto-temporal lobe degeneration (FTD), 37 with ALS/FTD, and 13 with psychiatric disorders. A familial history was present in 57 of the index cases (81%). In ALS and ALS/FTD cases with C9RE, the age of onset (AoO) was earlier than that in SALS cases, p < 0.0001 and p = 0.008, respectively. Sporadic cases with C9REALS (n = 13) had an earlier AoO compared to familial C9REALS ones, p < 0.0001. Within families, there was an earlier AoO in index cases and their siblings compared to their parental generation (p < 0.01). There was also a significant intrafamilial correlation for bulbar onset of ALS. The parental generation had significant female predominance compared to index cases and their siblings (sex ratio 0.47 vs. 1.4, p = 0.004), and this predominance was also present when considering parent–child pairs. In the group with psychiatric disorders, suicide was prominent (n = 9) and mean age was 54 years. Conclusion Although our sample size is rather limited, the earlier AoO in index cases and their siblings compared to the parental generation may suggest an anticipation. Reasons for predominance of female transmission are unclear, but the hypothesis that gender influences transmission of the genetic trait or C9RE size variation may be taken into account. Intrafamilial correlation suggests that genetic aspects underlie the occurrence of bulbar onset in ALS patients. Studies on larger samples are warranted to confirm those results.

[1]  E. Huey,et al.  Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms , 2019, Current Neurology and Neuroscience Reports.

[2]  R. Laforce,et al.  Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion. , 2019, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[3]  A. Chiò,et al.  Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients , 2019, Front. Neurosci..

[4]  J. Hodges,et al.  Psychiatric disorders in C9orf72 kindreds , 2018, Neurology.

[5]  P. Andersen,et al.  Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis , 2018, medizinische genetik.

[6]  A. Mendes,et al.  Clinical spectrum of C9orf72 expansion in a cohort of Huntington’s disease phenocopies , 2018, Neurological Sciences.

[7]  E. Rogaeva,et al.  Sex differences in the prevalence of genetic mutations in FTD and ALS , 2017, Neurology.

[8]  A. Chiò,et al.  Age-related penetrance of the C9orf72 repeat expansion , 2017, Scientific Reports.

[9]  K. Sleegers,et al.  Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion , 2017, JAMA neurology.

[10]  William T. Hu,et al.  Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population , 2016, Neurology.

[11]  M. Hiltunen,et al.  The role of the FTD-ALS associated C9orf72 expansion in suicide victims , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[12]  C. van Broeckhoven,et al.  A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories , 2014, Journal of Medical Genetics.

[13]  D. Calini,et al.  C9orf72 repeat expansions are restricted to the ALS-FTD spectrum , 2014, Neurobiology of Aging.

[14]  J. Kirby,et al.  The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype , 2014, Acta Neuropathologica.

[15]  O. Hardiman,et al.  Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population‐based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis , 2013, Annals of neurology.

[16]  D. Neary,et al.  Frontotemporal dementia with amyotrophic lateral sclerosis: A clinical comparison of patients with and without repeat expansions in C9orf72 , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[17]  Janel O. Johnson,et al.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.

[18]  A. Al-Chalabi,et al.  Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study , 2012, The Lancet Neurology.

[19]  Matthew C. Kiernan,et al.  Clinical diagnosis and management of amyotrophic lateral sclerosis , 2011, Nature Reviews Neurology.

[20]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[21]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[22]  T. Hanafusa,et al.  Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS , 2006, Neurology.

[23]  Ziyad Mahfoud,et al.  What Is an Intracluster Correlation Coefficient? Crucial Concepts for Primary Care Researchers , 2004, The Annals of Family Medicine.